The state of Florida currently has 54 active clinical trials seeking participants for Healthy research studies. These trials are conducted in various cities, including Miami, Tampa, Jacksonville and Orlando.
Single and Multiple Ascending Dose Study in Healthy Participants and Participants With an Autoimmune Disease
NCT06488209
Recruiting
The main purpose of this study is to to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity of LAD191 in healthy adults and in adults with an autoimmune disease.
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
10/16/2024
Locations: Doral Medical Research, Miami, Florida
Conditions: Healthy Volunteers, Autoimmune Disease
Register for Updates
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AJ302-IM in Healthy Volunteers
NCT06625541
Recruiting
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of AJ302-IM following intramuscular administration of single ascending doses in healthy volunteers.
Gender:
ALL
Ages:
Between 18 years and 55 years
Trial Updated:
10/01/2024
Locations: AnnJi Investigational Site, Miami, Florida
Conditions: Healthy Volunteers
Register for Updates
Study of Ciraparantag for Reversal of Anticoagulation Induced by Edoxaban, Apixaban or Rivaroxaban in Healthy Adults
NCT04593784
Recruiting
A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of ciraparantag for reversal of anticoagulation induced by different anticoagulant drugs in generally healthy adults as measured primarily by an automated coagulometer device.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
08/09/2024
Locations: Qps-Mra, Llc., South Miami, Florida
Conditions: Healthy
Register for Updates
A Study to Assess the Drug Levels of Repotrectinib in Healthy Participants and Participants With Moderate and Severe Hepatic Impairment
NCT06352528
Recruiting
The purpose of this study is to assess the drug levels of a single oral dose of repotrectinib in participants with moderate and severe HI, and in healthy matched control participants with normal hepatic function.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
07/10/2024
Locations: Local Institution - 0006, Miami Lakes, Florida +3 locations
Conditions: Hepatic Impairment, Healthy Volunteers
Register for Updates
A First in Human Trial Evaluating THB335 in Healthy Participants
NCT06425861
Recruiting
This study is a double blind, randomized, placebo-controlled, Phase 1 study in two parts: single ascending doses and food effect (Part 1) and multiple ascending doses (Part 2).
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
05/21/2024
Locations: QPS Miami, Miami, Florida
Conditions: Healthy
Register for Updates
A Community-Based Falls Prevention Program for Adults At-Risk for Falls
NCT05771818
Recruiting
The goal of this interventional study is to implement a Falls Prevention Program to impact the risk and injuries related to falls. The main question is to learn and examine the effects of a falls prevention program on the functional mobility of adults at risk for falls. Participants will: * Complete functional mobility assessments * Complete Falls prevention obstacle course training * Complete Falls Strategies Training * Complete walking and balance training
Gender:
ALL
Ages:
Between 18 years and 100 years
Trial Updated:
03/05/2023
Locations: University of St Augustine for Health Science, Miami, Florida
Conditions: Accidental Fall, Neurologic Disorder, Old Age; Debility, Healthy Aging
Register for Updates